DUBLIN, August 25, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the
"Top 25 Pharmaceutical Company Pipeline Analysis and Sales
Projections to 2025" report to their offering.
Top 25 Pharmaceutical Company Pipeline Analysis and Sales
Projections to 2025 examines the leaders in the pharmaceutical
industry, including the late-term pipeline of major companies. This
report provides long-term company sales forecasts based recent
market conditions.
For each company covered, the report provides:
- Corporate Summary
- Total Company Revenue and Total R&D Spending 2011-2015
- Break-up of Sales by Region, 2015
- Pharmaceutical Business Performance, 2011-2015 and Forecasted
2025
- Pharmaceutical Segment Sales, 2011 through 2015 and Forecasted
2025
- Leading Pharmaceutical Products, 2015 Sales
- Late Stage Product Pipeline
- Late Stage Product Pipeline by Therapeutic Area, Comparing
2009, 2011, 2013 and 2015
- Corporate Development Details
The companies covered in this study include:
- Pfizer
- Novartis
- Roche
- Merck
- Sanofi and 20 more
Top 25 Pharmaceutical Company Pipeline Analysis and Sales
Projections to 2025 provides a thorough discussion of current
trends in pharmaceutical research and development,
including:
- Pharmaceutical Research & Development Challenge
- The Drug Approval Process
- Expanded Options in Treating Diseases
- Biotechnology Drug Development
- Orphan Drugs
- Fast Track Drug Status
- Other Accelerated Methods for Drug Approval
- Pharmaceutical Regulatory Exclusivity
- The Role of Contract Research Organizations
In addition to its company focus, the report examines the global
pharmaceutical market, which has continued its recovery from the
economic downfall experienced in recent years. Healthcare costs as
a percent of GDP are increasing in almost all countries, though
there are some exceptions. There are a number of macroeconomic
concerns affecting sales such as aging populations, incidence of
disease, unmet medical needs, government activities, and
more.
Data provided include:
- Global Pharmaceutical Projects in Development by Therapeutic
Segment
- Global Pharmaceutical Market, 2011-2015 and Forecasted
2025
- Global Pharmaceutical Market by Therapeutic Area, 2011-2015 and
Forecasted 2025
- Total Healthcare Expenditures as a Percent of GDP by Country
2010 and 2015 Estimates (Australia, Austria, Canada, Czech
Republic, Finland,
France, Germany, Greece, Italy, Japan,
Mexico, Switzerland, United
Kingdom, United
States)
- International Population Trend Age 65+
For more information about this report visit
http://www.researchandmarkets.com/research/5tjnq3/top_25
Related Topics: Pharmaceuticals
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716